Join
Live feed
·
PRReleasevia Quantisnow
PLUS THERAPEUTICS Inc. logo

Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer

ByQuantisnow·Wall Street's wire, on your screen.
PSTV· PLUS THERAPEUTICS Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PSTV (PLUS THERAPEUTICS Inc.) and more on Quantisnow.